GleamWall
中文EN

QURE uniQure N.V.

Pharmaceutical Preparations · Nasdaq · SEC CIK 1590560 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY28.0%
TTM net income YoY1.0%
TTM EPS YoY20.2%
Revenue 3-yr CAGR-43.5%
Net income 3-yr CAGR—

Margins

Gross margin93.9%
Operating margin-1,001.7%
Net margin-1,154.8%
FCF margin-956.8%
EBITDA margin-921.0%

Returns

ROE-89.0%
ROA-25.5%
ROIC (approx.)—
Asset turnover0.02x

Leverage & solvency

Liabilities / assets68.7%
Debt / equity0.17x
Current ratio11.52x
Interest coverage-3.51x

Cash quality & payout

Operating cash flow / net income0.83x
Accruals ratio-4.4%
Payout ratio—
Capex / revenue3.7%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$16.10M$27.12M
Cost of revenue$1.69M$1.27M
Gross profit$14.41M$25.85M
R&D expense$140.67M$143.78M
SG&A expense$65.46M$52.66M
Operating income-$185.35M-$184.29M
Interest expense$61.99M$63.74M
Pretax income-$193.34M-$237.13M
Income tax$5.63M$2.43M
Net income-$198.97M-$239.56M
EBITDA-$170.59M-$171.65M
EPS (basic)-3.46-4.92
EPS (diluted)-3.46-4.92
Weighted avg. shares (diluted)57.50M48.65M
Balance sheet
Cash & equivalents$80.24M$160.33M
Receivables$5.86M—
Current assets$655.99M$390.29M
PP&E, net$13.80M$20.42M
Goodwill$25.36M$22.41M
Intangibles$72.79M$71.04M
Total assets$824.91M$556.54M
Current liabilities$62.92M$40.05M
Long-term debt$49.70M$51.32M
Total debt$49.70M$51.32M
Total liabilities$626.01M$563.29M
Shareholders' equity$198.90M-$6.75M
Net debt-$30.54M-$109.00M
Shares outstanding62.34M48.99M
Cash flow statement
Operating cash flow-$177.96M-$182.73M
Capital expenditure$439,000$3.37M
Free cash flow-$178.40M-$186.10M
Investing cash flow-$321.62M$162.97M
Financing cash flow$415.40M-$59.49M
Depreciation & amortization$14.76M$12.64M
Stock-based compensation$17.68M$22.26M

Free plan shows the latest 2 periods; Pro shows all 12 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.